The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

The Efficacy of Venetoclax in Multiple Myeloma

Shaji Kumar, MD
Published Online: 12:38 AM, Mon December 5, 2016

Shaji Kumar, MD, professor of medicine, Mayo Clinic, discusses the efficacy seen with venetoclax in multiple myeloma during the ASH Annual Meeting 2016.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.